SD-809

deutetrabenazine · Teva Pharmaceutical Industries

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SD-809, covering 2017-08-11 to 2017-08-11. Get the full timeline:

Most recent: Clinical Trial Update: First Time Use of SD-809 in Huntington Disease [Phase 3]